Articles tagged with “ai-in-drug-discovery”

A 2026 framework for prioritizing biotech AI use cases by impact, data readiness, and regulatory risk, with verified adoption, ROI, and FDA governance data.

Analyst report on AI in preclinical development in 2026: market size, FDA credibility framework and animal-testing roadmap, organ-on-chip adoption, and five named case studies.

An evidence-based analysis of 20 biotech startups poised for impact by 2026. Learn about key innovations in gene therapy, diagnostics, AI, and sustainability.

Learn how Retrieval-Augmented Generation (RAG) connects ELN, LIMS, and institutional knowledge for drug discovery. Updated for 2026 with FDA/EMA AI guidelines, Benchling AI agents, GraphRAG, and latest market data.

Learn how to measure AI ROI in drug discovery beyond cost and time savings. Updated for 2026 with 173+ AI clinical programs, Insilico's Phase IIa results, Recursion-Exscientia merger, and new FDA guidance. Key metrics for scientific outcomes, pipeline productivity, and commercial value.

Learn about the most in-demand pharma roles for 2025-2026. This analysis covers top pharmaceutical jobs in AI, advanced manufacturing, and clinical development, including $370B+ in US reshoring investments and workforce restructuring trends.

Learn to design a ChatGPT workshop for biotech professionals. Updated for GPT-5 and 2026 regulatory frameworks, this guide covers LLM fundamentals, practical use cases, and prompt engineering for life sciences.

Learn how to run private LLM inference for biotech. Updated for 2026 with NVIDIA Blackwell B200, Llama 4, FDA AI guidance, EU AI Act compliance, and on-premise deployment for data privacy, security, HIPAA compliance, and cost analysis